{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T02:47:20Z","timestamp":1764557240444,"version":"build-2065373602"},"reference-count":36,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","pathologyjournal.rcpa.edu.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology"],"published-print":{"date-parts":[[2011,1]]},"DOI":"10.1097\/pat.0b013e328340bb46","type":"journal-article","created":{"date-parts":[[2011,2,24]],"date-time":"2011-02-24T02:24:34Z","timestamp":1298514274000},"page":"40-47","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Quantitative analysis of the expression of TGF-alpha and EGFR in papillary thyroid carcinoma: clinicopathological relevance"],"prefix":"10.1016","volume":"43","author":[{"given":"Alfred King Yin","family":"Lam","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin Kwok-Pui","family":"Lau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vinod","family":"Gopalan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Luk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chung Yau","family":"Lo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1097\/PAT.0b013e328340bb46_bib0005","doi-asserted-by":"crossref","first-page":"4001","DOI":"10.1073\/pnas.75.8.4001","article-title":"Growth factors from murine sarcoma virus- transformed cells","volume":"75","author":"de Larco","year":"1978","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1097\/PAT.0b013e328340bb46_bib0010","doi-asserted-by":"crossref","first-page":"13614","DOI":"10.1016\/S0021-9258(17)43959-7","article-title":"Epidermal growth factor-like transforming growth factor. II. Interaction with epidermal growth factor receptors in human placenta membranes and A431 cells","volume":"258","author":"Massague","year":"1983","journal-title":"J Biol Chem"},{"key":"10.1097\/PAT.0b013e328340bb46_bib0015","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1126\/science.2422759","article-title":"Transforming growth factor-alpha: a more potent angiogenic mediator than epidermal growth factor","volume":"232","author":"Schreiber","year":"1986","journal-title":"Science"},{"key":"10.1097\/PAT.0b013e328340bb46_bib0020","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1001\/archotol.127.9.1075","article-title":"Expression of androgen receptor, epidermal growth factor receptor, and transforming growth factor alpha in salivary duct carcinoma","volume":"127","author":"Fan","year":"2001","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"10.1097\/PAT.0b013e328340bb46_bib0025","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1002\/mc.10103","article-title":"Hepatocyte growth factor, trans-forming growth factor alpha, and their receptors as combined markers of prognosis in hepatocellular carcinoma","volume":"36","author":"Daveau","year":"2003","journal-title":"Mol Carcinog"},{"key":"10.1097\/PAT.0b013e328340bb46_bib0030","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1046\/j.1365-2036.2001.01003.x","article-title":"Expression of hepatocyte growth factor, transforming growth factor alpha, apoptosis related proteins Bax and Bcl-2, and gastrin in human gastric cancer","volume":"15","author":"Konturek","year":"2001","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1097\/PAT.0b013e328340bb46_bib0035","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1007\/s00262-008-0630-2","article-title":"TGF-alpha as a candidate tumor antigen for renal cell carcinomas","volume":"58","author":"Pelletier","year":"2009","journal-title":"Cancer Immunol Immunother"},{"key":"10.1097\/PAT.0b013e328340bb46_bib0040","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1530\/eje.0.1320229","article-title":"Epidermal growth factor (EGF) and transforming growth factor alpha-stimulated invasion and growth of follicular thyroid cancer cells can be blocked by antagonism to the EGF receptor and tyrosine kinase in vitro","volume":"132","author":"Holting","year":"1995","journal-title":"Eur J Endocrinol"},{"key":"10.1097\/PAT.0b013e328340bb46_bib0045","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S1357-2725(99)00015-1","article-title":"EGF receptor","volume":"31","author":"Wells","year":"1999","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1097\/PAT.0b013e328340bb46_bib0050","first-page":"613","article-title":"EGFR and steroid receptors in ovarian carcinoma: comparison with prognostic parameters and outcome of patients","volume":"17","author":"Fischer-Colbrie","year":"1997","journal-title":"Anticancer Res"},{"key":"10.1097\/PAT.0b013e328340bb46_bib0055","first-page":"3","article-title":"The clinical significance of epidermal growth factor receptor (EGF-R) in human breast cancer: a review on 5232 patients","volume":"13","author":"Klijn","year":"1992","journal-title":"Endocr Rev"},{"key":"10.1097\/PAT.0b013e328340bb46_bib0060","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1385\/EP:16:4:323","article-title":"Papillary carcinoma of thyroid: a 30-year clinicopathological review of the histological variants","volume":"16","author":"Lam","year":"2005","journal-title":"Endocr Pathol"},{"key":"10.1097\/PAT.0b013e328340bb46_bib0065","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1530\/eje.0.1470741","article-title":"High prevalence of RET protooncogene activation (RET\/PTC) in papillary thyroid carcinomas","volume":"147","author":"Lam","year":"2002","journal-title":"Eur J Endocrinol"},{"key":"10.1097\/PAT.0b013e328340bb46_bib0070","doi-asserted-by":"crossref","first-page":"4183","DOI":"10.1158\/0008-5472.CAN-08-0413","article-title":"RET\/PTC-induced cell growth is mediated in part by epidermal growth factor receptor (EGFR) activation: evidence for molecular and functional interactions between RET and EGFR","volume":"68","author":"Croyle","year":"2008","journal-title":"CancerRes"},{"key":"10.1097\/PAT.0b013e328340bb46_bib0075","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1677\/erc.1.01226","article-title":"Differentiated thyroid cancer cell invasion is regulated through epidermal growth factor receptor-dependent activation of matrix metalloproteinase (MMP)-2\/gelatinase A","volume":"13","author":"Yeh","year":"2006","journal-title":"Endocr Relat Cancer"},{"key":"10.1097\/PAT.0b013e328340bb46_bib0080","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/path.2652","article-title":"An introduction to genes, genomes and disease","volume":"220","author":"Hall","year":"2010","journal-title":"J Pathol"},{"key":"10.1097\/PAT.0b013e328340bb46_bib0085","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.2165\/10489100-000000000-00000","article-title":"Gefitinib: a review of its use in the treatment of locally advanced\/metastatic non-small cell lung cancer","volume":"69","author":"Sanford","year":"2009","journal-title":"Drugs"},{"key":"10.1097\/PAT.0b013e328340bb46_bib0090","doi-asserted-by":"crossref","first-page":"3662","DOI":"10.1210\/jc.2006-0055","article-title":"Epidermal growth factor receptor as a therapeutic target in human thyroid carcinoma: mutational and functional analysis","volume":"91","author":"Mitsiades","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1097\/PAT.0b013e328340bb46_bib0095","doi-asserted-by":"crossref","first-page":"2744","DOI":"10.1002\/ijc.24250","article-title":"Epidermal growth factor receptor gene mutations in papillary thyroid carcinoma","volume":"124","author":"Masago","year":"2009","journal-title":"Int J Cancer"},{"key":"10.1097\/PAT.0b013e328340bb46_bib0100","series-title":"World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Endocrine Organs","first-page":"49","article-title":"Tumours of the thyroid and parathyroid","author":"DeLellis","year":"2004"},{"key":"10.1097\/PAT.0b013e328340bb46_bib0105","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1097\/01.sla.0000250445.92336.2a","article-title":"Staging systems for papillary thyroid carcinoma: a review and comparison","volume":"245","author":"Lang","year":"2007","journal-title":"Ann Surg"},{"key":"10.1097\/PAT.0b013e328340bb46_bib0110","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1097\/PAT.0b013e328340bb46_bib0115","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1002\/ijc.2910460308","article-title":"Co-expression of the genes encoding transforming growth factor-alpha and its receptor in papillary carcinomas of the thyroid","volume":"46","author":"Aasland","year":"1990","journal-title":"Int J Cancer"},{"key":"10.1097\/PAT.0b013e328340bb46_bib0120","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/ijc.2910550108","article-title":"Demonstration of a TGF-alpha- EGF-receptor autocrine loop and c-myc protein over-expression in papillary thyroid carcinomas","volume":"55","author":"Haugen","year":"1993","journal-title":"Int J Cancer"},{"key":"10.1097\/PAT.0b013e328340bb46_bib0125","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1038\/bjc.1993.432","article-title":"Prognostic impact of EGF- receptor in papillary thyroid carcinoma","volume":"68","author":"Akslen","year":"1993","journal-title":"Br J Cancer"},{"key":"10.1097\/PAT.0b013e328340bb46_bib0130","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1002\/(SICI)1097-0215(19960117)65:2<161::AID-IJC6>3.0.CO;2-X","article-title":"Cytoplasmic localization of EGF receptor in papillary thyroid carcinomas: association with the 150-kDa receptor form","volume":"65","author":"Ness","year":"1996","journal-title":"Int J Cancer"},{"key":"10.1097\/PAT.0b013e328340bb46_bib0135","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1002\/1097-0142(19951101)76:9<1643::AID-CNCR2820760922>3.0.CO;2-#","volume":"76","author":"Akslen","year":"1995","journal-title":"Cancer"},{"key":"10.1097\/PAT.0b013e328340bb46_bib0140","first-page":"291","article-title":"Expression of epidermal growth factor, transforming growth factor-alpha and epidermal growth factor receptor in thyroid tumors","volume":"6","author":"Gorgoulis","year":"1992","journal-title":"In Vivo"},{"key":"10.1097\/PAT.0b013e328340bb46_bib0145","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1089\/thy.1995.5.67","article-title":"Expression of growth factors and growth factor receptors in normal and tumorous human thyroid tissues","volume":"5","author":"van der Laan","year":"1995","journal-title":"Thyroid"},{"key":"10.1097\/PAT.0b013e328340bb46_bib0150","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.amjsurg.2008.01.008","article-title":"Evaluation of type 1 growth factor receptor family expression in benign and malignant thyroid lesions","volume":"195","author":"Wiseman","year":"2008","journal-title":"Am J Surg"},{"key":"10.1097\/PAT.0b013e328340bb46_bib0155","doi-asserted-by":"crossref","first-page":"8063","DOI":"10.1158\/1078-0432.CCR-05-0646","article-title":"Increased expression of vascular endothelial growth factor C in papillary thyroid carcinoma correlates with cervical lymph node metastases","volume":"11","author":"Yu","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1097\/PAT.0b013e328340bb46_bib0160","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/1423-0127-16-82","article-title":"Characterization of membranous and cytoplasmic EGFR expression in human normal renal cortex and renal cell carcinoma","volume":"16","author":"Pu","year":"2009","journal-title":"J Biomed Sci"},{"key":"10.1097\/PAT.0b013e328340bb46_bib0165","first-page":"734","article-title":"Differential expression of growth factors in squamous cell carcinoma and precancerous lesions of the lung","volume":"8","author":"Piyathilake","year":"2002","journal-title":"Clin Cancer Res"},{"key":"10.1097\/PAT.0b013e328340bb46_bib0170","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1136\/pgmj.2007.064881","article-title":"Follicular variant of papillary thyroid carcinoma: a diagnostic challenge for clinicians and pathologists","volume":"84","author":"Salajegheh","year":"2008","journal-title":"Postgrad Med J"},{"key":"10.1097\/PAT.0b013e328340bb46_bib0175","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1245\/s10434-006-9280-9","article-title":"Clinicopathological roles of alterations of tumor suppressor gene p16 in papillary thyroid carcinoma","volume":"14","author":"Lam","year":"2007","journal-title":"Ann Surg Oncol"},{"key":"10.1097\/PAT.0b013e328340bb46_bib0180","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1530\/eje.1.01883","article-title":"High prevalence of cyclooxygenase 2 expression in papillary thyroid carcinoma","volume":"152","author":"Lo","year":"2005","journal-title":"Eur J Endocrinol"}],"container-title":["Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031302516330665?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031302516330665?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T16:15:36Z","timestamp":1758471336000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0031302516330665"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,1]]}},"alternative-id":["S0031302516330665"],"URL":"https:\/\/doi.org\/10.1097\/pat.0b013e328340bb46","relation":{},"ISSN":["0031-3025"],"issn-type":[{"type":"print","value":"0031-3025"}],"subject":[],"published":{"date-parts":[[2011,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quantitative analysis of the expression of TGF-alpha and EGFR in papillary thyroid carcinoma: clinicopathological relevance","name":"articletitle","label":"Article Title"},{"value":"Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1097\/PAT.0b013e328340bb46","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Royal College of Pathologists of Australasia. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}